Access New Active Substance and Biosimilar Work Sharing Initiatives
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Read the press release from Medicines and Healthcare products Regulatory Agency published on 8 February 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (11 mars 2024). Access New Active Substance and Biosimilar Work Sharing Initiatives. ELSIBI. Consulté le 18 mars 2025 à l’adresse https://doi.org/10.58079/vzzv